CTMX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

CTMXCytomX Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

CTMXCytomX Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CTMX 9

ABBVAbbVie (formerly ImmunoGen)supplier

MRKMercksupplier

AMGNAmgensupplier

BMYBristol Myers Squibbcustomer

5 more · CTMX chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

CTMXCytomX Therapeutics, Inc.

2.16▼−8.30%

Mkt cap$512.1MRevenue$1MQ2 FY26Revenue$76MFY25

LLYELI Lilly & Co

1,380.54▼−2.64%

Regular sessionNov 5 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 5 '26

CTMXCytomX Therapeutics, Inc.

LLYELI Lilly & Co

2.16▼−8.30%

Price

1,380.54▼−2.64%

$512.1M

Mkt cap

$1.3T

Q2 FY26$1M

Revenue

$24.4BQ3 FY26

FY25$76M

Revenue

$65.2BFY25

CTMX2.16▼−8.30%vsLLY1,380.54▼−2.64%Regular sessionNov 5 '26